Trial Profile
Rifaximin Predicts the Complications of Decompensated Cirrhosis: a Randomized Controlled Trial
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Rifaximin (Primary)
- Indications Endotoxinaemia; Liver cirrhosis
- Focus Therapeutic Use
- 25 Mar 2014 New trial record